SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Euro. Regulatory News (JEGI)

Share Price Information for Jpmorgan Euro. (JEGI)

Share Price is delayed by 15 minutes
Get Live Data
146.20    3.00 (2.09%)
Bid:
146.20
Ask:
146.60
Spread: 0.40 (0.274%)
Market Cap: £617.50m
JEGI Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Euro. Share Chart

Dividend Declaration

1 Apr 2026 16:22

RNS Number : 1301Z
JPMorgan European Grwth & Inc PLC
01 April 2026
 

JPMorgan European Growth & Income plc

 

London Stock Exchange Announcement

Dividend for the year to 31st March 2027

 

Legal Entity Identifier: 549300D8SPJFHBDGXS57

Information disclosed in accordance with DTR 6.1.13

 

The Board is pleased to announce that it intends to pay dividends totalling 5.44 pence per share (four interim dividends of 1.36 pence per share) in relation to its financial year commencing 1st April 2026. This is in line with our policy of paying out a dividend based on 4.0% of the Company's preceding year net asset value and represents an increase of 8.8% on the last financial year's total dividend of 5.0 pence per share.

 

It is expected that the dividends will be paid by way of four equal distributions, with the first interim dividend for the financial year ending 31st March 2027 of 1.36 pence per share, being paid on 5th June 2026 to shareholders on the register at the close of business on 17th April 2026. The ex-dividend date is 16th April 2026. The three other dividends are expected to be paid in September, December and March.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ('DRIP'), which is managed by the Company's registrar. The last date for the DRIP election in respect of the Company's first interim dividend is 8th May 2026. For details on the DRIP, please contact the Company's Registrar; Computershare Investor Services.

 

Rita Dhut, the Chair of the Company, commented on the Company's dividends for the year ending 31st March 2027 as follows:

 

"It is the Board's intention to provide shareholders with a predictable and regular dividend based on 4% of the preceding year end net asset value ("NAV") per share. This represents an increase of 8.8% over the 5.0p paid in respect of the last financial year.

 

Since we adopted the enhanced dividend policy in 2022, shareholders in the Company have seen an increase in their dividends of 36.0%, equivalent to over 7.9% per annum, and we have delivered four consecutive annual dividend increases.

 

Such an approach is available to the Company because to the extent that brought forward revenue reserves are not sufficient, dividends can be paid from distributable capital reserves, as permitted by the Company's Articles."

 

 

For and on behalf of

JPMorgan Funds Limited, Secretary

1st April 2026

 

For further information:

JPMorgan Funds Limited

Company Secretary

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVIBMATMTTMBMF
Date   Source Headline
25th Nov 202411:27 amRNSGearing announcement
25th Nov 202410:53 amRNSNet Asset Value(s)
22nd Nov 202411:37 amRNSNet Asset Value(s)
21st Nov 20245:08 pmRNSTransaction in Own Shares
21st Nov 20244:50 pmRNSDividend Declaration
21st Nov 202411:38 amRNSNet Asset Value(s)
20th Nov 20245:03 pmRNSTransaction in Own Shares
20th Nov 202410:55 amRNSNet Asset Value(s)
19th Nov 202411:07 amRNSNet Asset Value(s)
18th Nov 20245:09 pmRNSTransaction in Own Shares
18th Nov 202412:15 pmRNSGearing announcement
18th Nov 202411:51 amRNSNet Asset Value(s)
15th Nov 202411:05 amRNSNet Asset Value(s)
14th Nov 20245:06 pmRNSTransaction in Own Shares
14th Nov 202410:55 amRNSNet Asset Value(s)
13th Nov 202410:45 amRNSNet Asset Value(s)
12th Nov 202411:16 amRNSNet Asset Value(s)
11th Nov 20245:11 pmRNSTransaction in Own Shares
11th Nov 20244:02 pmRNSTen Largest Investments
11th Nov 20241:34 pmRNSGearing announcement
11th Nov 202411:09 amRNSNet Asset Value(s)
8th Nov 202411:43 amRNSNet Asset Value(s)
7th Nov 20245:14 pmRNSTransaction in Own Shares
7th Nov 202411:10 amRNSNet Asset Value(s)
6th Nov 202410:47 amRNSNet Asset Value(s)
5th Nov 202410:49 amRNSNet Asset Value(s)
4th Nov 20245:05 pmRNSTransaction in Own Shares
4th Nov 202412:26 pmRNSGearing announcement
4th Nov 202411:13 amRNSNet Asset Value(s)
1st Nov 202411:43 amRNSNet Asset Value(s)
1st Nov 20249:21 amRNSTotal Voting Rights
31st Oct 202410:45 amRNSNet Asset Value(s)
30th Oct 202411:49 amRNSNet Asset Value(s)
29th Oct 20245:04 pmRNSTransaction in Own Shares
29th Oct 202412:06 pmRNSNet Asset Value(s)
28th Oct 20245:01 pmRNSTransaction in Own Shares
28th Oct 202412:09 pmRNSGearing announcement
28th Oct 202410:50 amRNSNet Asset Value(s)
25th Oct 202411:31 amRNSNet Asset Value(s)
24th Oct 20244:39 pmRNSHolding(s) in Company
24th Oct 202410:33 amRNSNet Asset Value(s)
23rd Oct 20245:08 pmRNSTransaction in Own Shares
23rd Oct 202410:57 amRNSNet Asset Value(s)
22nd Oct 20244:57 pmRNSTransaction in Own Shares
22nd Oct 202410:57 amRNSNet Asset Value(s)
21st Oct 20245:01 pmRNSTransaction in Own Shares
21st Oct 202411:35 amRNSGearing Announcement
21st Oct 202410:50 amRNSNet Asset Value(s)
18th Oct 202411:41 amRNSNet Asset Value(s)
17th Oct 20244:56 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.